MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Can We Rid Uganda of the Societal Myth That Parkinson’s Disease Is Witchcraft?

    S. Klingelhofer, H. Tamale, G. Mogan (Tillamook, USA)

    Objective: Educate rural Ugandans that Parkinson’s Disease (PD) is a scientific disorder, not contagious or the result of anything mystical Background: People with PD (PWP)…
  • 2024 International Congress

    Adult Onset Spastic Paraplegia in TUBB4A Leukodystrophy

    HJ. Kim, HJ. Ha, CY. Lee, JY. Yun (Seoul, Republic of Korea)

    Objective: Introduction: Leukodystrophies are primarily known as childhood diseases, but recent advances in genetic testing and brain imaging have led to an increase in reports…
  • 2024 International Congress

    Movement disorders in Brain Sagging Syndrome- A Systematic Review

    A. Datta, A. Lenka (Minneapolis, USA)

    Objective: Objective: This study aims to systematically review the array of movement disorders observed in patients diagnosed with brain sagging syndrome (BSS) secondary to spontaneous…
  • 2024 International Congress

    Delayed movement disorders after usage of desomorphine-“crocodile”. Clinical case.

    G. Ilina, D. Khasanova, Z. Zalyalova, A. Katok (Kazan, Russian Federation)

    Objective: To study the clinical and neuroimaging features of a patient with a long-term use (more than 10 years) of desomorphine in the anamnesis. Background:…
  • 2024 International Congress

    Instrument-supported Gait Analysis Characterizes Gait Domain Changes in Patients with Suspected Normal Pressure Hydrocephalus – a Retrospective Study

    C. Semmler (Cologne, Germany)

    Objective: This study aimed at further characterizing the gait of patients with clinically suspected Normal Pressure Hydrocephalus (NPH) by investigating changes in several gait domains…
  • 2024 International Congress

    PD Young Ambassadors: A Peer-led, Community-Based Intervention to Raise PD Awareness in the Hispanic Communities of Chicago.

    J. Deliz, E. Espinoza, S. Kola, E. Zivin, K. Williams, J. Adrissi, P. Gonzalez-Latapi, D. Larson (Chicago, USA)

    Objective: To employ a community-based participatory research (CBPR) approach in developing and testing a workshop-based, peer-led intervention aimed at increasing PD awareness among youth and…
  • 2024 International Congress

    Idiopathic Parkinson’s disease and Normal pressure Hydrocephalus – a tale of two sisters

    P. Vvsrk, S. Kola, R. Alugolu, R. Kandadani, R. Borgohain (Hyderabad, India)

    Objective: Idiopathic Parkinson's disease (PD) and Normal pressure hydrocephalus (NPH) can have similar clinical presentation. However, diagnostic precision is important as clinical management differs. Previous…
  • 2024 International Congress

    Movement Disorders in Anti-IGLON5 Antibody Disease

    S. Garg, J. Kaur, K. Karan, D. Nanduri (Bengaluru, India)

    Objective: To review demographic, clinical features, treatment trends, and responses in Anti-IgLON5 disease with a focus on movement disorders Background: Anti-IgLON5 antibody disease has emerged…
  • 2024 International Congress

    Hyposmia is Associated with Positive CSF α-Synuclein Seeding in Normal Pressure Hydrocephalus

    S. Weber, C. Farris, Y. Ma, M. Dakna, M. Starke, C. Trenkwalder, L. Concha-Marambio, B. Mollenhauer (Goettingen, Germany)

    Objective: To detect α-synuclein (αSyn) pathology and associated clinical characteristics in patients with idiopathic normal pressure hydrocephalus (iNPH) through cerebrospinal fluid (CSF) αSyn seed amplification…
  • 2024 International Congress

    Maintaining Isometric Contraction in Parkinson’s Disease: Effect of PD-Medication on EMG Amplitude

    B. Afsharipour, F. Roy, M. Schindle, F. Ba, M. Gorassini, T. Sankar (Edmonton, Canada)

    Objective: To quantify muscle activity changes in PD with dopaminergic medication. Background: Parkinson's disease (PD) is characterized by motor symptoms that improve with dopaminergic medication.…
  • « Previous Page
  • 1
  • …
  • 556
  • 557
  • 558
  • 559
  • 560
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley